The adenovirus early region 1A (E1A) oncoprotein mediates cell transformation by deregulating host cellular processes and activating viral gene expression by recruitment of cellular proteins that include cyclic-AMP response element binding (CREB) binding protein (CBP)/p300 and the retinoblastoma protein (pRb). While E1A is capable of independent interaction with CBP/p300 or pRb, simultaneous binding of both proteins is required for maximal biological activity. To obtain insights into the mechanism by which E1A hijacks the cellular transcription machinery by competing with essential transcription factors for binding to CBP/p300, we have determined the structure of the complex between the transcriptional adaptor zinc finger-2 (TAZ2) domain of CBP and the conserved region-1 (CR1) domain of E1A. The E1A CR1 domain is unstructured in the free state and upon binding folds into a local helical structure mediated by an extensive network of intermolecular hydrophobic contacts. By NMR titrations, we show that E1A efficiently competes with the N-terminal transactivation domain of p53 for binding to TAZ2 and that pRb interacts with E1A at 2 independent sites located in CR1 and CR2. We show that pRb and the CBP TAZ2 domain can bind simultaneously to the CR1 site of E1A to form a ternary complex and propose a structural model for the pRb:E1A:CBP complex on the basis of published x-ray data for homologous binary complexes. These observations reveal the molecular basis by which E1A inhibits p53-mediated transcriptional activation and provide a rationale for the efficiency of cellular transformation by the adenoviral E1A oncoprotein.
The adenovirus early region 1A (E1A) oncoprotein mediates cell transformation by deregulating host cellular processes and activating viral gene expression by recruitment of cellular proteins that include cyclic-AMP response element binding (CREB) binding protein (CBP)/p300 and the retinoblastoma protein (pRb). While E1A is capable of independent interaction with CBP/p300 or pRb, simultaneous binding of both proteins is required for maximal biological activity. To obtain insights into the mechanism by which E1A hijacks the cellular transcription machinery by competing with essential transcription factors for binding to CBP/p300, we have determined the structure of the complex between the transcriptional adaptor zinc finger-2 (TAZ2) domain of CBP and the conserved region-1 (CR1) domain of E1A. The E1A CR1 domain is unstructured in the free state and upon binding folds into a local helical structure mediated by an extensive network of intermolecular hydrophobic contacts. By NMR titrations, we show that E1A efficiently competes with the N-terminal transactivation domain of p53 for binding to TAZ2 and that pRb interacts with E1A at 2 independent sites located in CR1 and CR2. We show that pRb and the CBP TAZ2 domain can bind simultaneously to the CR1 site of E1A to form a ternary complex and propose a structural model for the pRb:E1A:CBP complex on the basis of published x-ray data for homologous binary complexes. These observations reveal the molecular basis by which E1A inhibits p53-mediated transcriptional activation and provide a rationale for the efficiency of cellular transformation by the adenoviral E1A oncoprotein.
CBP/p300 ͉ NMR ͉ protein structure ͉ transcriptional coactivator ͉ retinoblastoma protein T he adenovirus early region 1A (E1A) protein plays a central function in viral infection by activating genes required for viral replication and by deregulating the host cell cycle to force entry into S phase and repress differentiation (1) (2) (3) . E1A deregulates the cell cycle through interactions with key cellular proteins, including the general transcriptional coactivators cyclic-AMP response element binding (CREB) binding protein (CBP) and p300 (4, 5) and the retinoblastoma protein (pRb) (6) , which lead to epigenetic modifications and reprogramming of host cell transcriptional processes (7) . Binding of E1A to pRb displaces the E2F transcription factors, thereby relieving E2F repression and resulting in premature S-phase entry and transcriptional activation of E2F-regulated genes (8) (9) (10) . Association of E1A with CBP/p300 results in global hypoacetylation of K18 of histone H3 and may be linked to the ability of E1A to induce oncogenic transformation (11) . E1A is a multifunctional protein (12) composed of 4 conserved regions (CR1-CR4, Fig.  1A ). E1A uses both CR1 and CR2 for interaction with pRb (13, 14) . CR2 contains a characteristic pRb recognition motif, LX-CXE, which binds with high affinity to the B cyclin fold domain of the pRb pocket region (15, 16) . The CR1 region of E1A binds at the interface of the A and B cyclin folds of pRb, in a site that partially overlaps the binding site of E2F (17) . From the structural homology between E1A and E2F (18) , a L/IXXLY/F motif is implicated in the displacement of E2F from pRb by E1A (17) .
CR1 and CR2 function synergistically to enhance binding of E1A to pRb and efficiently disrupt the E2F complex (17) .
The transcriptional coactivator/acetyltransferase p300 was originally identified through its specific interaction with E1A (5); E1A also binds the close paralog CBP (4) . Interactions between E1A and CBP/p300 are central to its ability to transform cells and induce mitosis (2, 19) . In addition, E1A represses CBP/ p300-dependent transcriptional activity (20, 21) by binding to promoter-bound CBP/p300 (22) . By competing for binding to CBP/p300, E1A inhibits p53-mediated activation of p21 and other stress response genes and thereby suppresses cell cycle arrest and apoptosis (23, 24) . E1A has been variously reported to inhibit (21, 25) and to activate (26) the histone acetyltransferase (HAT) activity of CBP/p300.
E1A utilizes its N-terminal region (residues 1-25) and residues within the CR1 region to bind CBP/p300 (13, (27) (28) (29) (30) , although an additional weak interaction through CR3 has been reported (31) . The regions of CR1 that bind CBP/p300 and pRb appear to be distinct and nonoverlapping (28) . The primary E1A binding site on CBP/p300 (Fig. 1B) appears to be the transcriptional adaptor zinc finger-2 (TAZ2) (or CH3) domain (4, 5) although interactions with the nuclear coactivator binding domain and the KIX domain have also been reported (32, 33) . Simultaneous interaction of both CBP/p300 and pRb is necessary for maximal biological activity of E1A (34) .
To further our understanding of the mechanism by which E1A hijacks the cellular transcriptional machinery and deregulates the cell cycle, we have undertaken an NMR structural analysis of the interactions of E1A with CBP/p300 and pRb. In this paper, we report the solution structure of the CR1 region of E1A (residues 53-91) in complex with the TAZ2 domain of CBP and show that E1A competes efficiently with the transactivation domain of p53 for binding. Most significantly, we show that E1A is capable of forming a ternary complex with the CBP TAZ2 domain and the pocket domain of pRb, and we present a structural model of the ternary complex. Our experiments provide unique insights into the structural basis by which E1A targets key cellular proteins to subvert cellular control mechanisms and provide an optimal environment for viral replication.
Results and Discussion
Mapping the Interaction Sites of E1A with CBP. E1A binding has been mapped previously to the TAZ2 domain of CBP/p300 (5). Two regions of E1A are implicated in the interaction: the N-terminal region (residues 1-25) and the CR1 region (residues 42-80) (Fig. 1 A) (28) . It was necessary to truncate E1A for structural studies because the spectra of complexes formed with E1A constructs containing both binding regions were severely broadened [supporting information (SI) Table S1 ]. Heteronuclear single quantum coherence (HSQC) titrations using truncated E1A constructs representing the isolated N-terminal and CR1 regions showed that the primary interaction site for TAZ2 lies in CR1. Binding of E1A(1-36) is in intermediate exchange and causes extensive broadening of both TAZ2 and E1A cross peaks (Table S1 , Fig. S1 A) , whereas binding of E1A(53-91) is in slow exchange and gives rise to well dispersed cross peaks with uniform line widths (Fig. 2) . HSQC titrations were performed in which E1A(1-36) was titrated into the 15 N-TAZ2:E1A(53-91) complex. Cross peaks arising from TAZ2 residues within the E1A(53-91) binding site are unaffected by E1A , while resonances from residues on the opposite face of TAZ2 are shifted and/or broadened by E1A(1-36) binding (Fig. S1 C and D) . Thus, although the N-terminal region of E1A clearly binds to a distinct surface of TAZ2, the accompanying spectral broadening precludes determination of the bound structure.
Unbound E1A Is Intrinsically Disordered. Heteronuclear multidimensional NMR spectra of the complex of E1A(53-91) with TAZ2 were acquired, observing either isotope-labeled TAZ2 bound to unlabeled E1A or labeled E1A bound to unlabeled TAZ2. Over 90% of the 1 H, 13 C, and 15 N resonances were assigned for both TAZ2 and E1A. The peaks in the HSQC spectra of the free and bound TAZ2 domain are well dispersed ( Fig. 2 A) , indicating that TAZ2 is well folded in both states; nevertheless, binding of E1A results in large chemical shift perturbations. More dramatic differences are observed between the HSQC spectra of free and bound E1A (Fig. 2B ). E1A is largely unstructured in the free state as seen by the limited chemical shift dispersion in the 1 H dimension; backbone resonances of both E1A(53-91) and E1A(1-139) show little deviation of chemical shifts from random coil values ( Fig. S2 A and  B) . This result is consistent with functional studies where fully heat-denatured E1A injected into mammalian cells retains the ability to induce cellular transformation and other E1A functions (35) . Upon interaction with TAZ2, there are large changes in the E1A chemical shifts (Fig. S2C ) indicative of coupled folding and binding.
Structure of the TAZ2:E1A Complex. The structure of the complex of TAZ2 with E1A(53-91) was determined from distance and dihedral angle restraints derived from the NMR spectra. The structure statistics are summarized in Table 1 . The structure of TAZ2 in the complex with E1A is very well defined by the NMR data ( Fig. 3A) and is very similar to that of the free protein, with a backbone heavy atom (N, C␣, CЈ) root mean square deviation of 0.90 Å relative to the unbound state. The TAZ2 domain, which functions as a preformed helical scaffold for binding of disordered transcriptional activation domains (36), contains 4 ␣-helices (labeled ␣1Ϫ␣4) joined by 3 short loops that form binding sites for 3 zinc atoms (Fig. 3B ). The fold is stabilized by an extensive hydrophobic core and by coordination of zinc (36) .
E1A binds in a deep hydrophobic groove in the surface of TAZ2, formed at the interfaces between helices ␣ 1 /␣ 2 and ␣ 1 /␣ 3 , and buries Ϸ1400 Å 2 of the TAZ2 surface ( Fig. 3 B and C) . The E1A backbone is generally well ordered between residues P54 and L80, except for a short loop from D68 to V70; residues at the N terminus [A53 and the 4 preceding residues (GSHM) that are an artifact from cleavage of the fusion protein] and at the C terminus (L81-E91) do not interact strongly with TAZ2 and are disordered in the structure ensemble (Fig. 3A) . A well-defined ␣-helix is formed by residues E59-I65, with shorter helical turns between L72-V74 and L80-T82, and a compact loop between F66-A73. The interaction of E1A with TAZ2 is mediated primarily through an extensive network of hydrophobic interactions. The E1A helix (E59-I65) is bound in a deep hydrophobic groove formed between helix ␣ 1 of TAZ2 and the N terminus of ␣ 2 and is oriented almost perpendicular to ␣1 (Fig. 3 B and C) . Immediately beyond the helix, the aromatic ring of F66 projects into a hydrophobic pocket formed at the interface between the ␣1, ␣2, and ␣3 helices of TAZ2. The side chains of A61, V62, I65, F66, and I78 of E1A form a hydrophobic cluster that packs against an extensive hydrophobic surface formed by the side chains of I1773, C1776, M1799, V1802, L1823, A1825, and L1826 at the ␣1/␣2/␣3 interface of TAZ2 (Fig. 3D) . A second hydrophobic cluster, formed by M71, A73, and V74 of E1A, packs against V1802, P1818, and V1819 at the junction of helices ␣ 2 and ␣ 3 of TAZ2. With the exception of V74 and I78, these hydrophobic residues are strongly conserved among E1A serotypes (37) , consistent with their importance in mediating TAZ2 binding. Additional hydrophobic interactions are made by the side chains of L80 and T82, located in a short helical turn at the C-terminal end of the E1A interaction interface. Although I78, L80, and T82 are not well conserved among E1A serotypes, they appear to contribute to binding of AD5 E1A because constructs terminating at G77 interact more weakly with TAZ2 and give exchange-broadened NMR spectra. The side chain of F83 of E1A is disordered and interacts only weakly with TAZ2; it is not conserved in the E1A sequence.
The extensive intermolecular hydrophobic contacts are supplemented by complementary charge interactions between acidic side chains on E1A and Arg and Lys residues on TAZ2 (Fig. 3E ). E59 and E60 of E1A are in close proximity to K1798 and R1801 of TAZ2; acidic side chains are strongly conserved at both of these sites in all E1A serotypes (37) . The more weakly conserved E60 lies close to R1775 of TAZ2, and D79 forms a salt bridge with R1769 on the ␣ 1 helix of TAZ2. A small hydrophobic cluster, formed by the side chains of P67, V70, and L72, is exposed on the surface of E1A (Fig. 3E) . Because hydrophobic side chains are conserved at these positions (particularly 70 and 72) in the majority of E1A serotypes, it is possible that this cluster functions in recruitment of other proteins to the E1A:TAZ2 complex.
The structure of a TAZ2 complex with the transcriptional activation domain of STAT1 has recently been reported (38) . STAT1 also binds through an amphipathic helix, with complementary electrostatic interactions between acidic side chains on the surface of the helix and arginine residues on helix ␣ 1 of TAZ2. Although STAT1 and E1A interact with a similar region of the TAZ2 surface (Fig. 3F) , they adopt very different structures upon binding and differ significantly in their intermolecular interactions. In particular, the binding sites of the amphipathic helices of STAT1 and E1A are different; the STAT1 helix utilizes the hydrophobic groove between the ␣ 1 and ␣ 3 helices of TAZ2 that is occupied by residues I78-T82 of E1A. These results underscore the versatility of the TAZ2 domain for binding a diverse range of intrinsically disordered transcriptional activation domains and viral proteins.
E1A Competes with p53 for CBP/p300 (TAZ2) Interaction. E1A inhibits p53-dependent transcriptional activation and suppresses p53-induced cell cycle arrest and apoptosis by competing with p53 for binding to CBP/p300 (23, 24, 39, 40) . The p53 transactivation domain (TAD) interacts with 4 domains of CBP/p300 (TAZ1, KIX, TAZ2, and NCBD), with the highest affinity toward TAZ2 (41) . To test the hypothesis that E1A and p53 compete directly for TAZ2, p53(13-61) and E1A(53-91) were titrated into 15 Nlabeled TAZ2 and HSQC spectra were recorded. Addition of increasing amounts of p53(13-61) results in shifting and broadening of cross peaks in the HSQC spectrum of TAZ2 (Fig. S3 A  and B) ; a region of this spectrum is shown in Fig. 4A . Addition of equimolar E1A to the TAZ:p53 complex causes all TAZ2 cross peaks to shift to their characteristic positions in the HSQC spectrum of the binary TAZ2:E1A complex (Fig. 4A, Fig. S3C ), indicating that E1A displaces the p53 TAD from TAZ2. The changes in TAZ2 chemical shifts caused by binding of p53 map to the hydrophobic surface formed by the ␣1, ␣2, and ␣3 helices of TAZ2 (Fig. 4B) . This surface partially overlaps with the E1A binding surface such that the p53 TAD and E1A would necessarily compete for binding to the TAZ2 domain of CBP/ p300.
Interaction of E1A with pRb.
Interactions between the pRb pocket domain and 15 N-labeled E1A peptides were examined using HSQC titrations (Fig. S4) . As expected (16) , the LXCXE motif in CR2 binds with high affinity to pRb; there is a large increase in dispersion of the HSQC spectrum of E1A(106-139) in the presence of pRb and exchange is slow on the chemical shift timescale (Fig. S4A) . The affinity for CR1 is lower (14) and the HSQC spectrum of E1A(27-91) remains poorly dispersed in the presence of excess pRb; cross peaks corresponding to the pRb binding site (residues 39-51) are mostly broadened and those of adjacent residues (L32, S36, and A53) are shifted upon binding (Fig. S4B ). Interactions were also observed with a pseudo-LXCXE motif (LAVQE, residues 72-76 of E1A) located in the TAZ2 binding region of CR1. HSQC cross peaks associated with these residues are broadened and/or shifted upon binding of pRb to E1A or E1A(53-91) (Fig. S4C) . Binding of pRb to the LAVQE motif in CR1 is weak and pRb is readily displaced by TAZ2 (Fig. S4 D and E) .
Ternary Complex Formation by CBP/p300 (TAZ2), E1A, and pRb. While our NMR experiments confirm formation of binary complexes between E1A and TAZ2 and between E1A and pRb, in vivo studies show that simultaneous interaction of CBP/p300 and pRb in a multimeric complex with E1A is necessary for efficient oncogenic transformation (34, 42) . To investigate ternary complex formation, we performed HSQC titrations in which the pRb pocket domain was added to the E1A(27-91):TAZ2 complex. The cross peaks of residues V62, S69, M71, and A73 in the TAZ2 binding site of CR1 remain at their characteristic chemical shifts even after addition of a 3-fold excess of pRb (Fig. 5A, Fig. S5) , showing that pRb does not compete with TAZ2 for E1A binding. Upon titration with pRb, the A53 cross peak shifts in slow exchange from its position in the spectrum of the TAZ2 binary complex to its position in the binary E1A(27-91):pRb complex (Fig. 5B) while the cross peaks of many residues in the region 39-51 are broadened (Fig. S5) , confirming binding of pRb to its cognate site. Thus, despite the close proximity of the pRb and CBP/p300 binding sites in the E1A CR1 region, the NMR data provide unequivocal evidence that both TAZ2 and the pRb pocket domain can bind simultaneously to form a ternary TAZ2-E1A-pRb complex. Not surprisingly, significant line broadening accompanies formation of this large (Ϸ57 kDa) multiprotein complex.
Structural Model of the Ternary Complex.
We have used the x-ray structures of the pRb pocket domain in complex with residues 37-49 from the E1A CR1 region (17) and with the LXCXE motif from human papilloma virus (HPV) E7 (15), together with our NMR structure, to generate a model of the pRb:E1A:TAZ2 ternary complex (Fig. 5C ). Residues 37-49 of E1A bind in a deep groove at the interface of the A and B cyclin fold domains of pRb (17) , while residues 53-91 in the C-terminal half of CR1 interact with the TAZ2 domain of CBP/p300. Residues 92-120 of E1A were modeled as a long, flexible linker between the TAZ2 binding site in CR1 and the LXCXE motif (residues 122-126) in CR2. On the basis of the homology with HPV E7, the LXCXE motif of E1A is expected to bind in an extended ␤-like conformation within a shallow hydrophobic groove on the B domain of pRb (15) .
The E1A CR1 and CR2 regions function synergistically to displace E2F from pRb. It has been suggested that displacement proceeds by a mechanism that involves initial high-affinity binding of CR2 to the B domain of pRb, thereby allowing CR1 to compete effectively with E2F for binding to the hydrophobic interface between the A and B domains of pRb (17) . The CR1 and CR2 binding sites on pRb are 30 Å apart (17) . While CR1 and CR2 can bind independently to pRb, formation of a stable ternary complex with CBP/p300 requires the presence of a long flexible spacer between CR1 and CR2 (34) . The length requirements can be understood from the structural model (Fig. 5C) ; the CR1-CR2 linker must be long enough to allow simultaneous binding of CR1 and CR2 in their cognate sites on pRb and to accommodate binding of CBP/p300 without creating steric clashes. CR1 and CR2 are connected by a long (Ͼ30 residues) intrinsically disordered linker (43) (Fig. S2B ) in all sequenced E1A serotypes (37) . Our structural model of the ternary complex provides insights into the molecular basis by which E1A stimulates acetylation of pRb by CBP/p300. By forming a ternary complex with pRb and the TAZ2 domain, E1A brings pRb into close proximity with the neighboring HAT domain of CBP/p300 (Fig. 1B) , thereby promoting acetylation at K873 and K874 of pRb (44) . Acetylation at these sites hinders phosphorylation of pRb by cyclin-dependent kinases and enhances binding to the ubiquitin ligase MDM2, thereby regulating cell differentiation and promoting permanent cell cycle exit (44, 45) .
Functional Significance of Intrinsic Disorder in E1A. NMR spectra of E1A(1-139) have limited dispersion and are characteristic of a largely unstructured protein (Fig. S2 A) . Chemical shifts are close to random coil values except for residues E13-D21, which have a weak propensity (Ϸ30% population) for helical structure (Fig. S2B) . Thus, the NMR spectra are consistent with recent predictions that, except for CR3, E1A is intrinsically disordered (43) . There are 4 known binding motifs located between residues 1 and 139 of E1A; residues 1-25 (13, (27) (28) (29) and residues 54-83 (this work) form binding sites for CBP/p300, while residues 37-51 (CR1) and 121-129 (CR2) function in pRb binding. The 4 binding motifs are capable of functioning either independently or synergistically to mediate interactions with cellular proteins (i.e., E1A can function as a ''molecular hub'') (43) . In addition to CBP/p300 and pRb, the E1A domains interact with nearly 20 other cellular proteins to regulate cell cycling and suppress the cellular response to the adenoviral infection (2, 43, 46) . The incorporation of these interaction motifs within an intrinsically disordered region confers upon E1A the flexibility to target multiple cellular proteins and organize them combinatorially into higher-order complexes to efficiently disrupt cellular regulatory pathways and reprogram gene expression. This ability to bind multiple cellular targets probably underlies the opposing effects of E1A in cellular apoptosis. E1A can prevent apoptosis by inhibiting the CBP/p300-p53 interaction (23) or induce apoptosis by promoting formation of a pRb:MDM2:p53 multimeric complex and initiating E1A-dependent CBP/p300 acetylation of pRb (3, 44, 47) .
Materials and Methods
Protein Expression and Purification. The TAZ2 domain of mouse CBP (residues 1764 -1855) and the p53 transactivation domain (residues 13-61) were expressed and purified as described (36, 48) . The pRb central pocket and adenovirus serotype 5 (Ad5 and Ad6) E1A constructs were expressed in Escherichia coli BL21 (DE3) cells; details are given in SI Text. For NMR titrations, refolded TAZ2, the pRb pocket domain, p53 , and the various E1A constructs were dialyzed into buffer (20 mM Tris, 50 mM NaCl, 1 mM DTT, pH 6.8, unless otherwise noted in SI Text). Protein concentration was determined from the absorbance at 280 nm. For E1A and E1A(53-91), which contain no tyrosine or tryptophan, protein concentration was estimated by BCA assay (Pierce) or from peak intensities observed in analytical HPLC, calibrated against known protein concentrations. NMR Spectroscopy. Spectra were recorded using Bruker 600-, 800-, and 900-MHz spectrometers. The complex formed by addition of E1A(53-91) to TAZ2 was concentrated to Ϸ1.5 mM in 10 mM d10-Tris in D2O (pH 6.4) or 90% H2O/10% D2O (pH 6.8) buffer containing 1 mM DTT for NMR experiments. Several samples with different isotope labeling patterns were used to reduce spectral complexity. Resonances were assigned using standard multidimensional heteronuclear NMR experiments (49) . Details are given in SI Text.
Structure Calculations. Distance restraints were derived from 3D 13 C-and 15 Nedited nuclear Overhauser effect spectroscopy (NOESY)-HSQC and isotopefiltered and edited 3D NOESY-HSQC spectra with m ϭ 120 ms. Backbone dihedral angle restraints were imposed in helical regions. Initial structures were generated with the program CYANA (50) and refined by 2 cycles of restrained molecular dynamics-simulated annealing, using the AMBER 8 software package (51) . Details of the structure calculations are given in SI Text, and the NOE restraints assigned manually and through the CANDID program are listed in Tables S2 and S3. The structure was visualized using the program MOLMOL (52) and the quality was checked using PROCHECK-NMR (53). free (black), in the binary complex with TAZ2 (1:1.5 mol ratio, red), and in the ternary complex with both TAZ2 and pRb (1:1.5:3 mol ratio, green). (B) Regions of the same spectrum showing the cross peak of A53. As a reference, the spectrum of the binary E1A:pRb complex is superimposed in blue. Although the green and red cross peaks become broader due to formation of a high molecular weight complex, it is clear that pRb does not displace TAZ2 and vice versa. The full HSQC spectra are shown in Fig. S5 . (C) Structural model of the ternary pRb-E1A-TAZ2 complex. The model was generated using the crystal structure of the complex of pRb with E1A (CR1, residues 37-49) (PDB entry 2R7G) (17) , the NMR structure of the TAZ2-E1A(53-91) complex determined in this work, and the crystal structure of the HPV E7 peptide (DLYCYEQLN, homologous to residues 121-129 of E1A) (in CR2) containing the LXCXE motif that interacts with pRb (PDB entry 1GUX) (15) . The flexible linker between residues 83 and 120 of E1A is indicated schematically as a dotted line. The backbone structures of pRb, E1A, and TAZ2 are represented as ribbons and are colored gray, coral, and blue, respectively.
